Comparing the Efficacy of NCPAP and NIPPV in Infants with RDS after Extubation; A Randomized Clinical Trial

Najafian, Bita; Ansari-Benam, Iman; Torkaman, Mohammad; Khosravi, Mohammad Hossein

doi:10.30483/rijm.2019.118330

Comparing the Efficacy of NCPAP and NIPPV in Infants with RDS after Extubation; A Randomized Clinical Trial

Document Type : Original Article

Authors

¹ Department of Pediatrics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

² Student Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran

10.30483/rijm.2019.118330

Abstract

Background: Respiratory distress syndrome (RDS) is the most common respiratory disorder of premature infants and leading cause of mortality. The main progress in RDS management is attributable to prescription of surfactant for fastening pulmonary maturation.

Objectives: In this study we aimed to compare nasal continuous positive airway pressure (NCPAP) with nasal intermittent positive pressure ventilation (NIPPV) in infants with RDS lower than 1800 gr of birthweight.

Methods: In this randomized clinical trial, infants with confirmed diagnosis of RDS who underwent treatment with surfactant and mechanical ventilation were randomly allocated to two NCPAP and NIPPV groups. Duration of hospitalization, oxygen therapy, respiratory protection, need for re-intubation and complications were recorded in a pre-designed checklist.

Results: Eventually 60 (37 males and 23 females) infants with mean gestational ages of 31.73±1.72 weeks in NCPAP and 32.6±1.92 weeks in NIPPV group underwent analysis (p=0.096). Infants in NCPAP group underwent mechanical ventilation for a mean duration of 3.3±1.7 days; while it was 2.4±0.96 days for infants in NIPPV group (p=0.026). The mean received doses of surfactant was 2.36±0.66 in NCPAP and 1.9±0.25 in NIPPV group (p=0.005). After intervention, infants in NCPAP group had a mean arterial oxygen saturation of 91.36±3.03%; while it was 91.3±4.03% for those in NIPPV group (p=0.669). Mean arterial oxygen pressure was 67.6±6.91 mmHg in NCPAP group and 75.2±7.2 mmHg in NIPPV group after intervention (p=0.045).

Conclusion: We found that NIPPV is more effective than NCPAP in decreasing need for reintubation and invasive mechanical ventilation in premature infants with respiratory distress syndrome and it also shortens the duration of hospitalization.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1. Fanaroff AA, Martin RJ. Neonatal-perinatal medicine: diseases of thefetus and infant. 8thed. New York: Mosby; 2012. P. 1097-98.

2. Najafian B, Khosravi MH, Setayesh F, Shohrati M. Comparing the effect of inhaler N-acetyl cysteine and intravenous dexamethasone on respiratory distress syndrome in premature infants: a randomized clinical trial. Thrita. 2017;6(1):e46268. https://doi.org/10.5812/thrita.46268

3. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonatology. 2013;103(4):353-68. https://doi.org/10.1159/000349928 PMid:23736015

4. Vital FM, Ladeira MT, Atallah ÁN. Non‐invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev. 2013; 5:CD005351. https://doi.org/10.1002/14651858.CD005351.pub3 PMid:23728654

5. Stevens TP, Blennow M, Myers EH, Soll R. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;4:CD003063. https://doi.org/10.1002/14651858.CD003063.pub3 PMid:17943779 PMCid:PMC8554819

6. Najafian B, Karimi-Sari H, Khosravi MH, Nikjoo N, Amin S, Shohrati M. Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial. Contemp Clin Trials Commun. 2016;3:55-9. https://doi.org/10.1016/j.conctc.2016.04.003 PMid:29736457 PMCid:PMC5935855

7. Goldsmith JP, Karotkin E. Assisted ventilation of the neonate. New York: Elsevier Health Sciences; 2010 https://doi.org/10.1016/B978-1-4160-5624-9.00001-9 PMCid:PMC3174803

8. Najafian B, Esmaeili B, Khosravi MH. Comparison of fentanyl and midazolam for the sedation of infants under mechanical ventilation; a randomized clinical trial. Hosp Pract Res. 2017;2(3):63-7. https://doi.org/10.15171/hpr.2017.17

9. Najafian B, Eyvazloo H, Khosravi MH. Effects of different doses of fentanyl on the sedation of infants under mechanical ventilation; a randomized clinical trial. Hosp Pract Res. 2017;2(4):109-12. https://doi.org/10.15171/hpr.2017.26

10. Zaharie G, Ion DA, Schmidt N, Popa M, Kudor-Szabadi L, Zaharie T. Prophylactic CPAP versus therapeutic CPAP in preterm newborns of 28-32 gestational weeks. Pneumologia. 2007;57(1):34-7. [PubMed: 18543659].

11. Miksch RM, Armbrust S, Pahnke J, Fusch C. Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP. Eur J Pediatr. 2008;167(8):909-16. https://doi.org/10.1007/s00431-007-0646-1 PMid:18172681

12. Ho JJ, Henderson‐Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;2:CD002975. https://doi.org/10.1002/14651858.CD002975 PMCid:PMC7005359

13. Burns KE, Meade MO, Premji A, Adhikari NK. Noninvasive ventilation as a weaning strategy for mechanical ventilation in adults with respiratory failure: a Cochrane systematic review. CMAJ. 2014;186(3):E112-22. https://doi.org/10.1503/cmaj.130974 PMid:24324020 PMCid:PMC3928231

14. Nascimento RM, Ferreira AL, Coutinho AC, Santos Veríssimo RC. The frequency of nasal injury in newborns due to the use of continuous positive airway pressure with prongs. Rev Lat Am Enfermagem. 2009;17(4):489-94. https://doi.org/10.1590/S0104-11692009000400009 PMid:19820855

15. Reyburn B, Li M, Metcalfe DB, Kroll NJ, Alvord J, Wint A, et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med. 2008;178(4):407-18. https://doi.org/10.1164/rccm.200802-359OC PMid:18556628 PMCid:PMC2542442

16. Bisceglia M, Belcastro A, Poerio V, Raimondi F, Mesuraca L, Crugliano C, et al. A comparison of nasal intermittent versus continuous positive pressure delivery for the treatment of moderate respiratory syndrome in preterm infants. Minerva Pediatr. 2007;59(2):91-5. [PubMed: 17404558].

17. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007;150(5):521-6. https://doi.org/10.1016/j.jpeds.2007.01.032 PMid:17452229

18. Barrington KJ, Bull D, Finer NN. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics. 2001;107(4):638-41. https://doi.org/10.1542/peds.107.4.638 PMid:11335736

19. Khalaf MN, Brodsky N, Hurley J, Bhandari V. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics. 2001;108(1):13-7. https://doi.org/10.1542/peds.108.1.13 PMid:11433048

20. Khorana M, Paradeevisut H, Sangtawesin V, Kanjanapatanakul W, Chotigeat U, Ayutthaya J. A randomized trial of non- synchronized Nasopharyngeal Intermittent Mandatory Ventilation (nsNIMV) vs. Nasal Continuous Positive Airway Pressure (NCPAP) in the prevention of extubation failure in pre-term <1,500 grams. J Med Assoc Thailand. 2008;91(Suppl 3):S136-42. [PubMed: 19253509].

21. Gao W, Tan S, Chen Y, Zhang Y, Wang Y. Randomized trail of nasal synchronized intermittent mandatory ventilation compared with nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(7):524-6. [PubMed: 20637147].

22. Moretti C, Giannini L, Fassi C, Gizzi C, Papoff P, Colarizi P. Nasal flow‐synchronized intermittent positive pressure ventilation to facilitate weaning in very low‐birthweight infants: Unmasked randomized controlled trial. Pediatr Int. 2008; 50(1):85-91. https://doi.org/10.1111/j.1442-200X.2007.02525.x PMid:18279212

23. O'Brien K, Campbell C, Brown L, Wenger L, Shah V. Infant flow biphasic nasal continuous positive airway pressure (BP- NCPAP) vs. infant flow NCPAP for the facilitation of extubation in infants'≤ 1,250 grams: a randomized controlled trial. BMC Pediatr. 2012;12(1):43. https://doi.org/10.1186/1471-2431-12-43 PMid:22475409 PMCid:PMC3402979

24. Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS. A trial comparing noninvasive ventilation strategies in preterm infants. N Engl J Med. 2013;369(7):611-20. https://doi.org/10.1056/NEJMoa1214533 PMid:23944299

Razavi International Journal of Medicine

Article View: 241
PDF Download: 171

Comparing the Efficacy of NCPAP and NIPPV in Infants with RDS after Extubation; A Randomized Clinical Trial

References

Volume 7, Issue 2
April 2019
Pages 31-35

Files

Share

How to cite

Statistics

Comparing the Efficacy of NCPAP and NIPPV in Infants with RDS after Extubation; A Randomized Clinical Trial

References

Volume 7, Issue 2April 2019Pages 31-35

Files

Share

How to cite

Statistics

Volume 7, Issue 2
April 2019
Pages 31-35